198 related articles for article (PubMed ID: 30173054)
1. Barbaloin protects against lipopolysaccharide (LPS)-induced acute lung injury by inhibiting the ROS-mediated PI3K/AKT/NF-κB pathway.
Jiang K; Guo S; Yang C; Yang J; Chen Y; Shaukat A; Zhao G; Wu H; Deng G
Int Immunopharmacol; 2018 Nov; 64():140-150. PubMed ID: 30173054
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
3. Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways.
Qi S; Xin Y; Guo Y; Diao Y; Kou X; Luo L; Yin Z
Int Immunopharmacol; 2012 Jan; 12(1):278-87. PubMed ID: 22193240
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
5. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
[TBL] [Abstract][Full Text] [Related]
6. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
7. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
8. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
9. Astringin protects LPS-induced toxicity by suppressing oxidative stress and inflammation via suppression of PI3K/AKT/NF-κB pathway for pediatric acute lung injury.
Wang L; Jiang S; Li X; Lin T; Qin T
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2369-2377. PubMed ID: 37193771
[TBL] [Abstract][Full Text] [Related]
10. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
11. Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo.
Chen L; Liu P; Feng X; Ma C
J Cell Mol Med; 2017 Dec; 21(12):3178-3189. PubMed ID: 28905500
[TBL] [Abstract][Full Text] [Related]
12. 4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models.
Zeng M; Sang W; Chen S; Chen R; Zhang H; Xue F; Li Z; Liu Y; Gong Y; Zhang H; Kong X
Toxicol Lett; 2017 Apr; 271():26-37. PubMed ID: 28245985
[TBL] [Abstract][Full Text] [Related]
13. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
14. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.
Hyam SR; Lee IA; Gu W; Kim KA; Jeong JJ; Jang SE; Han MJ; Kim DH
Eur J Pharmacol; 2013 May; 708(1-3):21-9. PubMed ID: 23375938
[TBL] [Abstract][Full Text] [Related]
15. PI3K-γ inhibition ameliorates acute lung injury through regulation of IκBα/NF-κB pathway and innate immune responses.
Kim DI; Kim SR; Kim HJ; Lee SJ; Lee HB; Park SJ; Im MJ; Lee YC
J Clin Immunol; 2012 Apr; 32(2):340-51. PubMed ID: 22198681
[TBL] [Abstract][Full Text] [Related]
16. Potential chemoprevention of LPS-stimulated nitric oxide and prostaglandin E₂ production by α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranosyl-3-indolecarbonate in BV2 microglial cells through suppression of the ROS/PI3K/Akt/NF-κB pathway.
Dilshara MG; Lee KT; Choi YH; Moon DO; Lee HJ; Yun SG; Kim GY
Neurochem Int; 2014 Feb; 67():39-45. PubMed ID: 24486459
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
18. LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.
Li C; Yang D; Cao X; Wang F; Jiang H; Guo H; Du L; Guo Q; Yin X
Biochem Pharmacol; 2016 Aug; 113():57-69. PubMed ID: 27206337
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway.
Ma C; Zhu L; Wang J; He H; Chang X; Gao J; Shumin W; Yan T
J Ethnopharmacol; 2015 Jun; 168():349-55. PubMed ID: 25861954
[TBL] [Abstract][Full Text] [Related]
20. Thymol mitigates lipopolysaccharide-induced endometritis by regulating the TLR4- and ROS-mediated NF-κB signaling pathways.
Wu H; Jiang K; Yin N; Ma X; Zhao G; Qiu C; Deng G
Oncotarget; 2017 Mar; 8(12):20042-20055. PubMed ID: 28223539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
